The San Francisco-based lab will house Eli Lilly experts in biology, science and medicine alongside NVIDIA AI model builders ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area ...

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use ...

NVIDIA and Eli Lilly launch a $1 billion AI lab to speed drug discovery, improve manufacturing, and apply artificial ...

Tech giant Nvidia and pharma major Eli Lilly have announced a first-of-its-kind AI co-innovation lab focused on applying AI ...

Nvidia and Eli Lilly's AI tie-up shows drug discovery emerging as a new ETF growth theme across semiconductors and health ...

A multiyear co-innovation lab ties Eli Lilly’s drug pipeline to Nvidia’s next hardware cycle, betting faster discovery comes ...

Silicon Valley microprocessing giant Nvidia and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

Nvidia stock was languishing Monday despite news of a partnership with pharmaceutical company Eli Lilly. The chip company’s ...

Lilly has launched six early-stage clinical programs, and 34 discovery programs with a focus on incretins, amylins, and novel ...